Vestal Point Capital, LP Uni Qure N.V. Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
A detailed history of Vestal Point Capital, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Vestal Point Capital, LP holds 4,750,000 shares of QURE stock, worth $30.5 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
4,750,000
Previous 4,725,000
0.53%
Holding current value
$30.5 Million
Previous $24.6 Billion
13.39%
% of portfolio
1.59%
Previous 2.03%
Shares
3 transactions
Others Institutions Holding QURE
# of Institutions
142Shares Held
35.3MCall Options Held
1.54MPut Options Held
389K-
Nantahala Capital Management, LLC New Canaan, CT2.65MShares$17 Million0.79% of portfolio
-
Abrdn PLC1.93MShares$12.4 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.93MShares$12.4 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.9MShares$12.2 Million0.78% of portfolio
-
Schroder Investment Management Group London, X01.74MShares$11.2 Million0.01% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $300M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...